Publications by authors named "Julie Brevard"

Claim this Profile
O
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.
Stéphane de Botton, Pierre Fenaux, Karen Yee, Christian Récher, Andrew H Wei, Julie Brevard

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial.
Macarena I de la Fuente, Howard Colman, Mark Rosenthal, Brian A Van Tine, Danijela Levacic, Julie Brevard

Neuro Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial.
Justin M Watts, Maria R Baer, Jay Yang, Thomas Prebet, Sangmin Lee, Julie Brevard

Lancet Haematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of fatty acid synthase with FT-4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non-alcoholic fatty liver disease: Results from two early-phase randomized trials.
Carine Beysen, Patricia Schroeder, Eric Wu, Julie Brevard, Maria Ribadeneira

Diabetes Obes Metab· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D1 Agonist Improved Movement of Parkinsonian Nonhuman Primates with Limited Dyskinesia Side Effects.
Damon Young, Michael Popiolek, Patrick Trapa, Kari R Fonseca, Julie Brevard

ACS Chem Neurosci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.
Deepak M W Balak, Martijn B A van Doorn, Robert D Arbeit, Rianne Rijneveld, Erica Klaassen, Julie Brevard

Clin Immunol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histamine skin prick test: An analysis of the method for use in clinical trials.
Julie Brevard, Mary Anne Elder, Gary Berman, Ye Tan, Dmitri Volfson

Ann Allergy Asthma Immunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connecting to young adults: an online social network survey of beliefs and attitudes associated with prescription opioid misuse among college students.
Sarah Lord, Julie Brevard, Simon Budman

Subst Use Misuse· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teaching adolescents about changing bodies: Randomized controlled trial of an Internet puberty education and body dissatisfaction prevention program.
Tara M Cousineau, Debra L Franko, Meredith Trant, Diana Rancourt, Jessica Ainscough, Julie Brevard

Body Image· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MyStudentBody-Stress: an online stress management intervention for college students.
Emil Chiauzzi, Julie Brevard, Christina Thum, Stacey Decembrele, Sarah Lord

J Health Commun· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-minute skin anesthesia through ultrasound pretreatment and iontophoretic delivery of a topical anesthetic: a feasibility study.
Egilius L H Spierings, Julie A Brevard, Nathaniel P Katz

Pain Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis